Karl Bruce Thor

Title: Karl Bruce Thor: Innovator in Benzazepine Compounds

Introduction

Karl Bruce Thor is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues. With a total of 2 patents, his work focuses on innovative solutions for treating or preventing 5-HT receptor-related diseases.

Latest Patents

Thor's latest patents include a benzazepine compound that is useful as an agent for treating or preventing 5-HT receptor-related diseases. These diseases include incontinence, such as stress urinary incontinence, urge urinary incontinence, and mixed urinary incontinence. Additionally, his compounds target sexual dysfunction, including erectile dysfunction syndrome, and obesity. The benzazepine compounds developed by Thor exhibit excellent 5-HT receptor agonist activity, making them valuable in the medical field.

Career Highlights

Karl Bruce Thor is associated with Astellas Pharma GmbH, where he continues to innovate and contribute to pharmaceutical research. His work has been instrumental in advancing treatments that improve the quality of life for many patients suffering from various conditions.

Collaborations

Thor has collaborated with notable colleagues, including Hiroyuki Koshio and Norio Asai, to further enhance the research and development of his innovative compounds.

Conclusion

Karl Bruce Thor's contributions to the field of pharmaceuticals, particularly through his benzazepine compounds, highlight his role as a significant inventor. His work continues to pave the way for advancements in treating critical health issues.